Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|REGN||Regeneron Pharmaceuticals, Inc.||1.92%||562.71||2.7%||$439.86m|
|SNSS||Sunesis Pharmaceuticals, Inc.||0.98%||6.20||0.7%||$433.40m|
|GILD||Gilead Sciences, Inc.||-0.06%||66.86||1.0%||$412.81m|
|XLRN||Acceleron Pharma, Inc.||-0.71%||172.51||5.3%||$347.84m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.04%||185.49||1.9%||$269.88m|
|XENE||Xenon Pharmaceuticals, Inc.||1.81%||30.35||0.4%||$163.28m|
|CRSP||CRISPR Therapeutics AG||-1.89%||98.37||0.6%||$159.07m|
Sesen Bio, Inc. engages in designing, engineering, and developing of targeted protein therapeutics. It offers the Vicinium and Proxinium which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA.